North America Toxicology Laboratories Market Segmented By Product - Reagent and Kits(ELISA, PCR, Enzyme Multiplied Immunoassay Technique (EMIT), Radio Immuno-sorbent Assay (RIA)) | Instruments(Immunochemistry Analyzers, PCR Machine, Gas Chromatography/Mass Spectrometry (GS/MS), High Performance Liquid Chromatography(HPLC))
Industry: Healthcare
Published Date: March-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 169
Report ID: PMRREP9707
The revenue from the North America toxicology laboratories market stands at US$ 200.7 Mn in 2022, with the market expected to grow at a CAGR of 11.1% to reach a valuation of approximately US$ 640.9 Mn by the end of 2033.
|
Attribute |
Details |
|---|---|
|
Market Size (2022) |
US$ 200.7 Mn |
|
Projected Market Value (2033) |
US$ 640.9 Mn |
|
Global Market Growth Rate (2023-2033) |
11.1% CAGR |
As assessed by Persistence Market Research, amphetamines hold a market share of around 25.8% by drug class, in 2022. Overall, North America toxicology laboratories market sales account for approximately 3.3% revenue share in the global drug abuse testing market, which was valued at around US$ 6.1 Mn in 2022.
The market recorded a historic CAGR of 10.5% in the last 6 years from 2016 to 2022.
Toxicology labs have been undergoing a potential technical change as a result of the increasing need for drug toxicity testing, particularly for controlled substances.
Many manufacturers use high-throughput screening assays, or "rapid chemical screening technologies," to quickly and effectively screen thousands of chemicals for potential effects on people and the environment while reducing the number of laboratory animal-based toxicity tests that must be performed.
For instance, Draper and Bristol-Myers Squibb worked together in June 2019 to develop a special liver tissue model to evaluate the toxicity of drugs. Major players in the business are working on strengthening their production capabilities.
Small-scale toxicology laboratories in North America are adopting novel toxicity testing and screening technology as a result of the increased foot traffic in the region. These facilities are switching from slow testing procedures to rapid testing techniques.
For instance, Enzo Biochem, Inc. announced in August 2018 that it had agreed to buy a commercial building in Farmingdale, New York, with a total area of roughly 36,000 square feet, in order to advance its expansion strategy for diagnostic and therapeutic products.
Toxicology testing is increasingly being employed in the North American market as a result of the stringent regulatory standards that government officials are implementing to stop the misuse of substances that are restricted by law.
The United States Prohibited Substances Act regulates the production, distribution, and administration of controlled substances throughout the country.
A uniform legal framework is established under the Controlled Substances Act (CSA) to govern specific medicines that are thought to be at danger of abuse and dependency. Drugs that are distributed lawfully or illegally, for medical or recreational purposes, may be subject to the CSA. Drug testing of employees at their place of employment is required under these stringent government regulations. Additionally, insurance service providers run toxicological tests before providing any compensation to the claimant.
Additionally, it has grown to be very challenging to identify the unknown substances, especially in forensic toxicology labs without sensitive and specialized equipment that enables them to analyse that molecular structure.
Additionally, these laboratories now can conveniently and quickly enhance their liquid chromatography-mass spectrometry (LC-MS) techniques for specific targeting and screening and quantitative determination as they face the challenges of trying to analyse an increasing number of analytes in biological matrices.
Thus, owed to the above-mentioned factors, the market is likely to show high growth over the coming years at a CAGR of 11.1% and reach a market size of US$ 640.9 Mn by 2033.
“Market Consolidation, Technological Advancements, and Adoption of Cloud Based Systems”
Businesses in the toxicology laboratories market are looking to strengthen their positions through partnerships, acquisitions, and collaborations with other small- and medium-sized businesses in the industry.
In order to advance their technology and diversify their product offering by developing new solutions, these companies collaborate with smaller or medium-sized businesses and acquire such industries. Toxicological drug screening is most commonly done using gas chromatography-mass spectrometry (GC-MS).
With GC-MS methods, general unknown analysis—a comprehensive screening method—screens for more than 4,000 compounds. The traditional toxicological testing devices market is very prevalent in the US and Canada due to the significant consumption of prohibited substances in these countries.
Because of their fast turnaround times, ease of use, and superior sensitivity, these devices enable researchers to emphasize on the precise detection of parent drugs and their respective metabolites.
Therefore, it is anticipated that these devices will propel the expansion of the toxicology laboratories market due to the high performance they offer at a minimal price.
Additionally, it is anticipated that competitors in the North American toxicology laboratories market will benefit from lucrative growth opportunities due to the increased government expenditure on toxicology testing to counter illicit substance consumption.
For instance, the Florida Department of Health said in December 2019 that four Florida institutions had received US$ 650,000 in funds that had been specifically allocated by the government for a new program to test humans for medical conditions from severe toxicity.
Furthermore, the test findings from the forensic sample contain private information that must be submitted to numerous authorities. Such sensitive results are evaluated and archived in toxicological libraries via cloud storage technologies. Such cloud-competing technologies in the toxicity testing industry are now being embraced gradually. These technologies will have profitable market growth potential in the future, as more samples are now being analysed for abusive usage.
“Emergence of Point-of-Care Tests and High Cost of Conventional Toxicology Tests”
It is anticipated that the market for toxicology laboratories in North America will be severely affected by the advent of point-of-care toxicology testing devices.
There is a high need for portable toxicological testing equipment as a result of the growing abuse of controlled substances.
Therefore, businesses are focusing their efforts on developing point-of-care toxicological testing apparatus. Point-of-care toxicological test equipment could eventually take market share away from traditional toxicology laboratories, limiting market expansion.
For instance, in April 2019, Neogen developed a portable version of their Raptor Integrated Analysis Platform, enabling testers to do mycotoxin testing wherever they prefer, instead of only in the lab.
Traditional toxicological testing is not particularly efficient; hence, the individual must undertake a confirmatory test, which raises the approach's overall cost.
The adoption of conventional toxicity testing procedures in essential drug testing, where only a small amount of sample is obtained, has decreased as a result of their lack of effectiveness.
Traditional methods also require a large sample, which may be challenging to obtain in times of emergency, in order to detect the presence of harmful substances.
This is an additional key factor in the constrained commercial utilisation toxicological testing in laboratories.
Why is the U.S. Market Booming?
“Growing Consumer Awareness and Cost Advantages of Conventional Toxicology Labs”
The U.S. holds around 82.8% share of the North America market in 2022.
Over the projected period, a rise in consumer awareness of traditional toxicological testing methods is anticipated to fuel market expansion in North America. Because of the significant consumption of controlled substances in the U.S, there is a considerable demand for conventional toxicological testing equipment in the nation.
The majority of forensic toxicology facilities that get public funding rely on traditional testing tools. This is because these devices offer outstanding performance at a low price. Due to the economic advantages, toxicology laboratories in hospitals and diagnostic testing facilities heavily rely on conventional technologies, thus propelling the U.S. market.
What is the Outlook of the Market in Canada?
“Rising Cases of Opioid Consumption”
Canada holds around 17.2% share of the North America market in 2022.
Demands on their forensic laboratories have escalated as a result of the recent legalisation of cannabis in Canada and the expansion of the country's opioid crisis. This pattern has exacerbated the problem for forensic labs, along with the advent of COVID-19.
A significant increase in overdose deaths and increased demand on forensic laboratories, public health, and mental health care have been caused by a combination of isolation, convenient access to funds, and other social factors.
Which Drug Class is Driving Demand within the Global Market?
“High Cases of Substance Abuse”
Amphetamines hold around 25.8% of the total market in 2022.
There is a lot of amphetamine usage, and an overdose is known to have serious effects on the circulatory and nervous systems. Amphetamines have been a class of medications that are abused in many regions of the world since the 1930s. Amphetamine toxicity typically happens when it is used recreationally. Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA), which is a derivative of METH, are highly misused substances.
METH can be inhaled, smoked, injected, or taken orally and comes in several forms. The National Institute on Drug Abuse states that smoking METH is the most popular method of abuse, making it the main focus of the market.
Which Product is Largely Adopted within the Global Market?
“Laboratory Utility of Reagents and Samples”
Reagent and kits hold around 57.7% of the total market in 2022. A reagent can be used to test for the presence of a certain chemical by inducing a reaction with it. A reagent is necessary for each and every chemical reaction. Reagents, which are chemicals or molecules that can cause a reaction, are utilised in the majority of frequently performed tests.
Using reagents and kits in the laboratory setting, the clinical toxicology laboratory seeks to identify and monitor chemicals, medicines, or poisons in patient samples.
Which Sample Aids towards the Largest Share in the North America Market?
“Efficacy in Illicit Drug Identification”
Urine samples hold around 61.2% of the total market in 2022.
Since most drugs are metabolised and eliminated through urine, the majority of drug toxicology tests are conducted on urine samples. Tests on the urine are qualitative and can identify several different illegal drugs. For detecting drugs of abuse, urine is the most frequently employed matrix.
The fact that urine specimens are well-known specimens, that drugs concentrate in urine, and that they are simple to analyse are all advantages of using urine samples.
Which End User Provides the Market With a Large Share?
“Rising Cases of Illicit Substance Abuse and Presence of Established Forensic Toxicology Labs”
The forensic laboratories segment held a share of about 48.8% in 2022.
Forensic toxicology is the study of biological materials to detect the presence of poisons, including pharmaceuticals. The toxicology report can be used to determine the type of substances that are found in an individual as well as whether their quantity falls within the range of a therapeutic dosage or is more than the limit for harm.
In the United States, forensic toxicology has three subfields: human performance toxicology, post-mortem toxicology, and forensic drug testing (FDT). Postmortem toxicology is the study of the effects of drugs, alcohol, and poisons on biological samples taken during an autopsy.
Leading instrument and reagent manufacturers are enhancing their core competencies by introducing new products. Companies are focusing on making adjustments in order to attain the best results in the shortest amount of time.
Manufacturers focus on improving their manufacturing capacity and market presence to meet the increased demand for toxicology services. Different innovations are positioned to highlight their unique selling proposition in order to be accepted by consumers (USP).
Some key instances of development within the market include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the North America toxicology laboratories market, which are available in the full report.
|
Attribute |
Details |
|---|---|
|
Forecast Period |
2023-2033 |
|
Historical Data Available for |
2016-2022 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Drug Class:
Product:
Sample:
End User:
Country:
To know more about delivery timeline for this report Contact Sales
The market is currently valued at around US$ 200.7 Mn in 2022.
Sales of the market are set to witness growth at a CAGR of 11.1% and be valued at around US$ 640.9 Mn by 2033.
Demand for the market increased at a 10.5% CAGR from 2016 to 2022.
The U.S. accounts for around 82.8% share of the market in 2023.
Canada is set to expand at a CAGR of around 12.3% during the forecast period.
Amphetamines account for around 25.8% share of the market in 2023.
Reagent and kits account for around 57.7% share of the market in 2022.
Urine samples account for around 61.2% share of the market in 2022.
Forensic laboratories account for around 48.8% share of the market in 2022.
Thermo Fisher Scientific, Inc, Danaher Corporation, and Agilent Technologies, are the three key players in the market.
